题名 | Comparison of Fixed-Dose Combinations of Telmisartan/ Hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a Fixed-Dose Combination of Losartan/Hydrochlorothiazide 50/12.5 mg in Mild to Moderate Essential Hypertension: Pooled Analysis of Two Multicenter, Prospective, Randomized, Open-Label, Blinded-End Point (PROBE) Trials | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/15887845 |
本帖最后由 xiyu 于 2017-10-16 11:52 编辑
|